Categories: All postsAnalysts

EnWave Corp has a 52 per cent upside, Industrial Alliance says

Look for EnWave Corporation (EnWave Corporation Stock Quote, Chart TSXV:ENW) to keep its positive momentum rolling into 2019, says analyst Neil Linsdell of Industrial Alliance Securities. Ahead of the company’s first quarter fiscal 2019 report due on February 28, the analyst is maintaining his “Buy” rating and $2.35 target price, representing a projected 12-month return of 51.6 per cent at the time of publication.

Makers of commercial-scale dehydration platforms, EnWave is seeing success with its Moon Cheese product out of its NutraDried wholly owned subsidiary, while the company continues to expand in the cannabis space.

In a research update to clients Thursday, Linsdell notes that EnWave is building cannabis company Tilray’s third REV (Revolutionary Dehydration Technology) unit, bringing its capacity to 130kW. The Green Organic Dutchman joined as a sub-licensee last month, ordering its first unit and Your Wasabi Farms expanded its license to use its REV unit to dry industrial hemp. Finally, last April EnWave announced a TELOA with one of Canada’s largest licensed producers (still unnamed) and an exclusive option to license its technology for processing cannabis in a European country.

For ENW’s Q1/19, Linsdell expects revenue growth of 68 per cent to $7.6 million and Adj. EBITDA to $1.5 million from $0.3 million a year prior and EPS of $0.01 per share, up from negative $0.01 per share.

“Ongoing announcements of progress and orders with partners across various markets provide further support to our positive outlook, which includes still significant growth from EnWave’s wholly owned subsidiary NutraDried, as it continues to roll out Moon Cheese snacks through Costco divisions across the US,” says Linsdell.

The analyst sees EnWave generating Adj. EBITDA in 2019 of $9.4 million on revenue of $22.8 million and Adj. EBITDA in 2020 of $14.7 million on a top line of $54.7 million.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: enw
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Chorus Aviation price target trimmed at CIBC

Following first quarter results, CIBC analyst Kevin Chiang has lowered his price target on Chorus Aviation (Chorus Aviation Stock Quote,… [Read More]

7 hours ago

Is Magellan Aerospace stock a buy?

Its first quarter results are in the books and Paradigm Capital analyst J Marvin Wolff thinks there is money to… [Read More]

1 day ago

Phunware is undervalued, Roth says

Ahead of the company's first quarter results, Roth MKM analyst Darren Aftahi thinks there is money to be made on… [Read More]

1 day ago

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

1 day ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

2 days ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

2 days ago